Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.
about
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseasesRegulation of tumour necrosis factor signalling: live or let dieCD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitisQuantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assayBlimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.TNF blocking therapies and immunomonitoring in patients with inflammatory bowel diseaseCultured blood T-cell responses predict anti-TNF therapy response in patients with ulcerative colitis.Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis.Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
P2860
Q28067245-3E009551-3749-4437-AC1A-1051FBFBD6F0Q28262381-7423BD44-D531-4855-877B-F449FAC70D2CQ33695285-1BD7DFCB-4B1A-4C19-AE74-87C677B1777BQ33745965-B27F57EE-032C-4B1E-BDFE-22FD9946D55AQ35893711-81E41898-7666-436C-AA36-90089C43C2C1Q38206507-A5604C8A-EE9D-4D8C-9D2F-F63467445F2FQ39019746-895D3FA1-030C-4152-919C-6B682CAD899AQ41033177-0DE6BE73-C805-49D3-B939-E265FDA59828Q41067868-9F1A59F1-E3F7-4376-9119-438241118D1DQ48203221-A2F4FE79-DDC9-4B5B-BD39-FE1375C8B237Q53060269-69C1D60B-124B-469A-9C99-D9157FD268A0
P2860
Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
Infliximab inhibits activation ...... lly active ulcerative colitis.
@nl
type
label
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
Infliximab inhibits activation ...... lly active ulcerative colitis.
@nl
prefLabel
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
Infliximab inhibits activation ...... lly active ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
P2093
A Lundgren
M K Magnusson
S Isaksson
S Raghavan
P2860
P304
P356
10.1111/SJI.12081
P577
2013-09-01T00:00:00Z